health.miro operates as a physician-led preventive longevity clinic in West London. Medical leadership is provided by Dr. Miriam Mikicki, MD, MRCGP, IFMCP, a UK-trained general practitioner with certification in functional medicine and training in Traditional Chinese Medicine. Clinical oversight includes structured physician review cycles rather than technician-led testing models.
The clinic follows a diagnostics-first workflow:
Pre-visit intake → Extended biomarker testing → Physician interpretation → Structured report → Follow-up review cycle.
Testing may include panels exceeding 100 biomarkers, GI360 stool analysis, DUTCH hormone metabolite testing, Organic Acids Testing (OAT), and composite biological age modelling. Data is reviewed by physicians before any intervention is discussed. Raw data is not delivered without clinical interpretation.
health.miro applies a three-level routing structure:
Level 1 – Baseline Risk Mapping
Standard biomarker panel, lifestyle assessment, structured physician consultation.
Level 2 – Deep Phenotyping
Expanded hormone metabolites, microbiome testing, metabolic pathway analysis, biological age assessment.
Level 3 – Complex Case Integration
Multi-system evaluation with potential specialist referral when pathology exceeds preventive scope.
This structured escalation model prevents unnecessary intervention intensity while allowing diagnostic depth where clinically indicated.
For executives and international patients, consultation blocks are scheduled to minimise disruption to work commitments. Remote reporting sessions are available following on-site diagnostics.
Executive Time Efficiency
health.miro operates on an appointment-based structure designed for individuals with demanding schedules. Diagnostic sequencing and consultation blocks are organised to minimise fragmentation of time while maintaining analytical depth.
Remote follow-up consultations are available when clinically appropriate. This allows continuity of care for patients who travel frequently or manage international business commitments. Monitoring and reassessment can be coordinated without requiring prolonged physical presence in London.
At a Glance – Clinic Snapshot
|
Category
|
Details
|
|
Location
|
220c Blythe Road, London, United Kingdom
|
|
Clinic Type
|
Private physician-led outpatient longevity clinic
|
|
Core Focus
|
Preventive medicine, biomarker analysis, biological age modelling
|
|
Typical Stay
|
Outpatient visits; no overnight stay required
|
|
Diagnostic Depth
|
100+ biomarker panels, GI360 stool test, DUTCH hormone test, OAT, biological age models
|
|
Signature Method
|
MIRO Method (Measure, Implement, Reinforce, Optimise)
|
|
Environment
|
Urban clinical setting in West London
|
|
Privacy Level
|
GDPR-compliant data governance, physician-led review
|
|
Professional Recognition
|
Led by UK-licensed GP (MRCGP) with IFM certification
|
Many visitors integrate consultations and diagnostic sessions at health.miro into existing professional schedules rather than planning extended health stays. The clinic’s West London location at 220c Blythe Road supports structured appointments that can be coordinated efficiently within defined time windows.
Initial physician-led consultations and diagnostic sequencing are organised in scheduled blocks to minimise disruption to business commitments. Follow-up reporting sessions may occur in person or via telemedicine where appropriate. Most visitors arrange independent accommodation nearby in West London, Kensington, or Hammersmith depending on preference and travel logistics.
Accommodation is not operated by the clinic. Visitors commonly select business hotels or serviced apartments within short distance of the clinic, allowing discretion and ease of movement between professional commitments and medical appointments.
🔗 Explore nearby hotels & apartments
Use the Quick Links below to navigate directly to the sections most relevant to your review.
Executives and high-performing professionals typically seek structured medical clarity rather than general wellness experiences. health.miro differentiates itself through named diagnostics, physician-led interpretation, and a defined escalation framework rather than lifestyle positioning.
Key structural differentiators include:
- Extended biomarker panels exceeding 100 parameters
- GI360 stool microbiome testing
- DUTCH hormone metabolite analysis
- Organic Acids Testing (OAT) for metabolic pathway assessment
- Composite biological age modelling using multi-marker algorithms
- The MIRO Method (Measure, Implement, Reinforce, Optimise)
The clinic does not rely on trend-driven interventions or high-volume treatment models. Interpretation remains physician-led. Data is contextualised within cardiovascular, metabolic, inflammatory, endocrine, and mitochondrial systems before any decision is made.
Structural advantages include:
- Defined three-level routing architecture
- Scheduled physician reporting cycles
- GDPR-compliant data governance
- Outpatient format compatible with professional schedules
- Clear referral pathways when pathology exceeds preventive scope
The clinic’s model separates diagnostics from outcomes. Biomarker findings indicate risk patterns and system strain. They do not predict certainty or guarantee prevention.
This structure appeals to individuals who value measured oversight, risk transparency, and medical governance rather than experiential positioning.
health.miro is structured around preventive oversight rather than reactive treatment. The clinic’s stated purpose is to identify early biological deviation before the development of clinically diagnosed disease. This includes metabolic instability, inflammatory load, hormonal imbalance, mitochondrial strain, and early cardiovascular risk markers.
The clinic does not frame aging as a condition to be reversed. Instead, it treats aging as a measurable biological trajectory influenced by biomarker trends, lifestyle exposure, and cumulative system stress. Composite biological age models are used as directional tools, not predictive guarantees.
The objective is long-term planning support. Through repeated measurement and physician review cycles, patients receive structured insight into trend movement rather than one-time laboratory interpretation. Risk is assessed probabilistically, and recalibration occurs through scheduled review rather than episodic reaction.
There is no urgency framing. The clinic operates within a measured model designed for informed decision-making.
Clinical Purpose
The clinic’s clinical purpose can be summarised across three pillars:
- Early Risk Identification
Identification of metabolic, inflammatory, endocrine, and mitochondrial patterns before overt pathology develops.
- System-Level Understanding
Integration of cardiovascular, glycaemic, hormonal, renal, and inflammatory markers within one interpretive framework rather than siloed specialty review.
- Long-Term Planning Support
Structured follow-up cycles designed to monitor biomarker trajectory and adjust lifestyle or medical oversight accordingly.
This framework is informational and governance-based. It does not promise disease prevention or outcome certainty.
Who This Clinic Is Designed For
health.miro is structured for individuals seeking analytical medical oversight rather than symptom-driven consultation.
health.miro is structured for:
- Executives managing sustained cognitive load
- Founders and entrepreneurs under chronic stress exposure
- Investors and professionals seeking data-driven risk insight
- Professional athletes requiring structured metabolic and recovery assessment
- High-performers seeking clarity on biomarker trends rather than symptomatic treatment
It is not positioned for acute illness management, inpatient care, or emergency intervention. It serves individuals seeking structured preventive analysis under physician supervision.
health.miro operates under the MIRO Method — Measure, Implement, Reinforce, Optimise. This framework structures how data is collected, interpreted, and reviewed over time. It is not a treatment protocol. It is a sequencing model for clinical oversight.
The clinic distinguishes preventive medicine from reactive medicine. Reactive medicine typically intervenes once disease thresholds are met. The MIRO Method focuses on identifying deviation before diagnostic thresholds are crossed. Extended biomarker panels, hormone metabolite testing, microbiome analysis, and biological age modelling are used to detect patterns of strain rather than late-stage pathology.
Physician interpretation remains central. Raw laboratory outputs are not treated as conclusions. Cardiovascular markers are reviewed alongside inflammatory markers. Hormone metabolites are interpreted within a metabolic context. Glycaemic trends are assessed in relation to sleep and muscle mass indicators. The method deliberately avoids trend-driven interventions or unverified technologies.
Research in longitudinal cohort studies has shown associations between accelerated biological age markers and increased risk of multimorbidity. These findings inform risk framing but do not establish certainty at the individual level.
Core System Focus
The clinic places primary emphasis on metabolic and inflammatory regulation as central coordinating systems.
This includes:
- Glycaemic stability (fasting glucose, HbA1c, insulin dynamics)
- Inflammatory markers (CRP and related panels)
- Lipid metabolism
- Renal and hepatic indicators
- Hormone metabolite pathways
- Mitochondrial function proxies through Organic Acids Testing
Rather than isolating a single system, the clinic interprets interaction patterns across these domains.
|
🔍 Did You Know?
Longitudinal cohort analyses (e.g., Moffitt et al., 2017) suggest that accelerated biological aging markers are associated with higher transition rates from single chronic conditions to multimorbidity.
|
Lifestyle as a Medical Tool
Lifestyle factors are interpreted as modifiable variables within the clinical model.
This may include structured nutritional recalibration, sleep architecture alignment, muscle mass preservation, and glycaemic variability monitoring through continuous glucose tracking when appropriate.
Lifestyle is not positioned as motivational coaching. It is treated as a variable influencing biomarker trajectories. Adjustments are reviewed during scheduled physician reporting cycles.
|
🔍 Did You Know?
Observational research suggests that sustained physical activity is associated with more favourable aging biomarker profiles, though causality remains under investigation.
|
health.miro operates within a diagnostics-first model. Clinical interpretation begins with structured measurement rather than symptomatic assumptions. The objective is to identify biological strain patterns, early deviation, and inter-system interaction before disease thresholds are crossed.
Testing depth is determined by clinical presentation and executive objectives. Not all patients undergo maximum-level diagnostics. Escalation follows relevance, not marketing intensity.
Diagnostic Assessment Includes
Depending on clinical indication, assessment may include:
- Extended functional blood panels (often exceeding 100 biomarkers)
- Inflammatory markers including C-reactive protein (CRP)
- Glycaemic markers such as fasting glucose and HbA1c
- Lipid profiling
- Renal and hepatic indicators
- DUTCH hormone metabolite testing
- GI360 stool microbiome analysis
- Organic Acids Testing (OAT) for metabolic pathway insight
- Composite biological age modelling
- Continuous Glucose Monitoring (CGM) when indicated
All laboratory outputs undergo physician interpretation. Individual values are not treated as standalone conclusions. Pattern recognition across systems guides reporting.
Chronomedicine & Future Risk Mapping
health.miro incorporates temporal pattern recognition into its oversight model. Biomarker trends are evaluated across time rather than as isolated snapshots. This approach aligns with principles of chronomedicine, where timing and pattern movement inform interpretation.
Future risk mapping at the clinic is probabilistic. Biological age acceleration, inflammatory burden, glycaemic instability, and hormonal shifts are used to estimate directional risk rather than outcome prediction.
Reporting cycles are structured:
Baseline measurement → Physician interpretation → Follow-up review → Trend reassessment.
This iterative model supports long-term planning rather than episodic reaction.
health.miro’s strengths lie in interpretive integration rather than procedural volume. The clinic does not position itself around high-intensity intervention. Its value is derived from structured biomarker analysis, physician oversight, and longitudinal reporting cycles.
Below are three areas where the clinic demonstrates defined medical strength.
Key Medical Strength 1 – Multi-System Biomarker Integration
health.miro integrates cardiovascular, glycaemic, inflammatory, endocrine, renal, and hepatic markers within a single interpretive framework. Rather than reviewing panels in isolation, physicians assess cross-system interaction patterns.
For example:
- Glycaemic markers are reviewed alongside inflammatory load.
- Hormone metabolites are interpreted in a metabolic context.
- Lipid profiles are analysed in relation to renal indicators and inflammatory markers.
This integration reduces the risk of over-correcting single abnormal values without understanding the broader system context.
|
🔍 Did You Know?
Longitudinal research suggests that accelerated biological age markers are associated with higher transition rates from single chronic conditions to multimorbidity. These associations inform risk framing but do not establish individual certainty.
|
Key Medical Strength 2 – Hormone & Metabolic Pathway Analysis
The clinic uses DUTCH hormone metabolite testing and Organic Acids Testing (OAT) to evaluate endocrine and metabolic pathway function beyond standard serum hormone levels.
Hormone metabolites are interpreted alongside:
- Glycaemic regulation
- Sleep patterns
- Stress exposure
- Inflammatory markers
This layered approach allows differentiation between symptomatic hormone fluctuation and systemic metabolic strain.
The clinic does not position hormone testing as performance enhancement. It is used for pattern clarification within physician-led governance.
Key Medical Strength 3 – Structured Review Cycles
health.miro applies scheduled reporting and review cycles rather than one-time consultation models.
The structured sequence includes:
- Baseline biomarker mapping
- Physician interpretation session
- Defined review interval
- Trend reassessment
This model supports long-term oversight rather than episodic intervention.
The clinic’s focus remains on measurable trajectory movement rather than short-term symptom response.
The following summaries reflect individual experiences described within the clinic’s published materials. They illustrate diagnostic sequencing and physician interpretation rather than guaranteed results. Outcomes vary based on baseline health status, adherence, and biological variability.
Case 1: Persistent Fatigue with Normal Routine Tests
Before:
An executive reported ongoing fatigue, nausea, and cognitive slowing despite routine primary care blood tests returning within standard reference ranges.
After:
Expanded assessment identified iron deficiency, low vitamin D status, and gastrointestinal imbalance. Following physician-guided nutritional recalibration and monitoring, the individual reported improved energy and a reduction in persistent nausea over subsequent months.
Source:
Clinic-published patient experience summary.
Case 2: Insulin Resistance & Metabolic Instability
Before:
A professional experiencing bloating, fluid retention, and fluctuating energy levels was found to have early glycaemic instability and markers consistent with insulin resistance.
After:
Through structured dietary recalibration, metabolic monitoring, and follow-up biomarker review, glycaemic markers improved and reported energy levels stabilised over time.
Source:
Clinic-published patient case description.
|
⚠️ Editorial Note
These outcomes reflect individual experiences reported within the clinic’s published materials. Results vary. Biomarker analysis indicates risk patterns and biological strain, not certainty. Outcomes depend on multiple individual factors including baseline health, adherence, genetics, and environmental exposure.
|
Case 3: Hormonal & Gastrointestinal Complexity
Before:
A patient presented with migraines, anxiety, abdominal discomfort, and suspected small intestinal bacterial overgrowth (SIBO), alongside indicators of hormonal imbalance.
After:
Integrated diagnostics identified gastrointestinal dysbiosis and low thyroid function. Following physician-led evaluation and monitored intervention, the patient reported improved digestive stability and reduced migraine frequency over time.
Source:
Clinic-published patient experience summary.
|
⚠️ Editorial Note
Hormonal and gastrointestinal conditions require individualised interpretation. Biomarker findings indicate biological patterns, not certainty of outcome. Reported improvements reflect individual experience and are not predictive of uniform results.
|
health.miro structures its programs around diagnostic sequencing and physician interpretation rather than fixed treatment packages. Programs are outpatient-based and customised following baseline assessment. They are not residential stays and do not operate on a retreat model.
Durations below reflect typical engagement structure rather than guaranteed timelines.
Health Optimisation Programme (8–12 Weeks)
Format:
The outpatient program is structured across diagnostic intake, reporting sessions, and scheduled follow-up review cycles.
Clinical Focus:
Persistent fatigue, reduced cognitive clarity, frequent infections, metabolic inefficiency, and inflammatory burden.
Diagnostics May Include:
- Extended biomarker panel (100+ markers)
- Organic Acids Testing (OAT)
- Inflammatory markers (CRP and related indicators)
- Glycaemic markers (HbA1c, fasting glucose)
- Lipid profile
- Nutritional status markers
Program Structure:
- Pre-visit intake and baseline mapping
- Laboratory testing
- Physician interpretation session
- Structured lifestyle and monitoring plan
- Review cycle at defined interval
The program focuses on identifying root contributors to symptom patterns rather than addressing isolated complaints. Outcomes vary based on baseline physiology and adherence.
Female Hormones & Weight Loss Programme(10–16 Weeks)
Format:
Two-phase outpatient program integrating endocrine analysis and metabolic review.
Clinical Focus:
Perimenopause, menopause, hormonal imbalance, metabolic instability, weight fluctuation, and mood changes.
Diagnostics May Include:
- DUTCH hormone metabolite testing
- Glycaemic markers
- Inflammatory markers
- Lipid profile
- Thyroid function panels
Program Structure:
- Hormonal baseline assessment
- Metabolic evaluation
- Physician interpretation
- Monitoring and review cycle
Where clinically appropriate, conventional therapies such as Hormone Replacement Therapy (HRT) or GLP-1 medications may be discussed within established medical guidelines. These are considered under physician supervision and not positioned as performance tools.
Results depend on individual biology and compliance with structured oversight.
Skin Health Programme(8–12 Weeks)
Format:
Outpatient integrative program combining biomarker testing and microbiome analysis.
Clinical Focus:
Chronic inflammatory skin conditions such as acne, rosacea, and psoriasis.
Diagnostics May Include:
- GI360 stool testing
- Inflammatory markers
- Nutritional markers
- Hormone assessment where indicated
Program Structure:
- Baseline inflammatory and microbiome mapping
- Physician interpretation
- Structured nutritional and lifestyle adjustments
- Follow-up reporting cycle
The program interprets dermatological presentation within gastrointestinal, inflammatory, and endocrine context. It does not promise resolution or cure.
These programs operate within preventive oversight parameters. They are designed for structured review and longitudinal monitoring rather than short-term intervention intensity.
health.miro operates as a private outpatient medical clinic in West London. It does not provide inpatient admission, residential recovery stays, or retreat-style accommodation. All services are delivered through scheduled consultations, structured diagnostics, and defined review cycles.
The clinic integrates functional medicine diagnostics with conventional medical oversight. Interventions are selected based on physician interpretation of laboratory findings and system interaction patterns.
Medical & Restorative Therapies
Therapies discussed within the clinic’s framework may include:
- Structured functional nutrition protocols
- Targeted nutraceutical supplementation
- Low Dose Naltrexone (LDN) under physician supervision
- Peptide bioregulators aimed at cellular signalling pathways
- Hormone Replacement Therapy (HRT) when clinically indicated
- Continuous Glucose Monitoring (CGM) for glycaemic variability analysis
These therapies are not prescribed generically. They are considered only after diagnostic review and within medical guidelines. The clinic does not promote experimental or trend-driven interventions.
Clinical Facilities
health.miro functions as an urban outpatient clinic. Diagnostics are conducted through accredited laboratory partners. On-site consultations focus on:
- Physician-led reporting sessions
- Interpretation of extended biomarker panels
- Hormone metabolite review
- Microbiome test analysis
- Structured risk mapping discussions
The clinic does not operate imaging suites or inpatient treatment wards. Where advanced diagnostics exceed outpatient scope, referral pathways are defined.
Architecture, Environment & Digital Discipline
The clinic operates within a professional urban medical setting in West London. It is not a spa environment. The setting prioritises privacy, discretion, and structured consultation rather than experiential design.
Digital discipline is maintained through secure data storage systems compliant with GDPR regulations. Laboratory results, biological age modelling outputs, and clinical notes are stored within controlled-access systems.
The outpatient model allows patients to integrate visits within work schedules rather than requiring extended absence from professional commitments.
Governance & Privacy
health.miro operates under United Kingdom medical regulatory standards. Clinical oversight is provided by a UK-licensed General Practitioner (MRCGP) with certification in functional medicine (IFMCP). All diagnostic interpretation is physician-led.
Laboratory testing is conducted through accredited external providers operating under recognised quality assurance frameworks. Raw laboratory data is not interpreted by automated systems alone. Physician review remains mandatory before any structured plan is discussed.
Patient data handling complies with the General Data Protection Regulation (GDPR). Clinical notes, biomarker results, biological age modelling outputs, and hormone testing data are stored within secure, access-controlled systems.
The clinic maintains defined escalation pathways. When diagnostic findings indicate pathology outside preventive scope, referral to appropriate medical specialists is advised. The clinic does not position itself as a replacement for specialist care.
Longevity modelling, biomarker interpretation, and risk mapping operate within probabilistic frameworks. Governance is based on measurement, interpretation, and documented review cycles — not on guarantees of prevention or outcome certainty.
health.miro structures pricing around diagnostic depth, physician interpretation time, and scheduled review cycles. The clinic does not operate on volume-based packages or promotional pricing models. Fees reflect the scope of testing, reporting sessions, and ongoing oversight.
Costs vary depending on the level of diagnostic assessment selected and the length of follow-up required. Supplementation, prescription medications, additional laboratory panels, or specialist referrals are billed separately where applicable.
No program guarantees specific health outcomes. Pricing reflects structured medical oversight rather than performance promises.
Pricing
|
Category
|
Details
|
|
Clinic Positioning
|
Private physician-led outpatient longevity clinic
|
|
Stay Length
|
Outpatient visits; no overnight stay required
|
|
Entry Pricing
|
Provided upon consultation planning
|
|
What’s Included
|
Diagnostic testing (as selected), physician interpretation session, structured reporting
|
|
Additional Costs
|
Supplements, medications, extended laboratory panels, specialist referrals
|
|
Program Structure
|
Baseline testing → Physician review → Defined follow-up cycle
|
|
Clinical Principle
|
Measurement-driven oversight within probabilistic risk framework
|
Pricing is discussed transparently prior to diagnostic sequencing.
How Programs Are Structured
Programs follow a defined workflow:
Pre-visit preparation
Medical history intake and diagnostic planning.
On-site diagnostics
Laboratory sampling and structured assessment.
Physician interpretation
Comprehensive review session integrating cross-system biomarker analysis.
Reporting & Follow-up
Defined review cycle assessing trend direction and recalibration where appropriate.
This structure separates measurement from decision-making and emphasises physician oversight.
Length of Stay
health.miro operates exclusively as an outpatient clinic.
- No inpatient admission
- No residential accommodation
- No retreat-style programming
Initial visits may be completed within scheduled consultation blocks. Follow-up reviews may be conducted remotely where appropriate.
The clinic is designed to integrate within professional schedules rather than require extended absence from work.
health.miro is located at 220c Blythe Road in West London, United Kingdom. The clinic operates strictly by appointment. It does not accept walk-in visits and does not provide residential accommodation.
Most patients integrate consultations into existing business travel or professional schedules rather than planning extended stays. The outpatient model allows structured diagnostics and reporting sessions to be completed within defined time blocks.
Recommended Length of Stay
As an outpatient clinic, health.miro does not require overnight stays.
Initial diagnostic appointments may be completed within one or two scheduled visits. Follow-up reporting sessions are typically conducted separately and may be arranged remotely when appropriate.
The duration of engagement depends on the depth of diagnostic sequencing selected and the interval between review cycles.
How to Reach the Clinic?
health.miro is accessible via major London transport infrastructure.
- Nearest Airport: London Heathrow Airport
- Typical Transfer Time: Approximately 30–45 minutes by car, depending on traffic
- Transport Options: Private car service, taxi, or rail connections via central London
For travel planning convenience:
🔗 Find best flights to London
🔗 Find car rentals in London
Links provided for travel planning convenience only.
Accommodation & Stay Planning
health.miro does not operate on-site accommodation. Patients travelling from outside London typically arrange independent lodging nearby.
West London offers serviced apartments and business-oriented hotels suitable for short stays aligned with consultation schedules.
🔗 Explore nearby hotels & apartments
What to Bring
Patients are advised to bring:
- Prior laboratory results (if available)
- Medication list
- Relevant imaging reports
- Personal identification
No specialised equipment or athletic gear is required unless advised during pre-visit planning.
The longevity sector remains heterogeneous. There is no globally standardised framework governing preventive longevity clinics. Models range from wellness-oriented retreats to highly medicalised outpatient clinics. As a result, due diligence requires evaluation of physician leadership, diagnostic specificity, regulatory compliance, and reporting structure.
health.miro positions itself as a physician-led outpatient clinic operating within UK medical regulation. It uses named diagnostics, including extended biomarker panels (100+ markers), GI360 microbiome testing, DUTCH hormone metabolite analysis, Organic Acids Testing, and composite biological age modelling. Interpretation is conducted by a licensed General Practitioner rather than automated reporting systems.
Outcomes in longevity medicine are inherently probabilistic. Associations between biological age acceleration, inflammatory burden, metabolic instability, and multimorbidity progression are supported by longitudinal cohort research. However, these associations do not predict individual certainty. Diagnostics indicate directional risk patterns, not guaranteed outcomes.
Within the broader sector, health.miro’s positioning can be characterised by:
- Physician-led governance rather than technician-led delivery
- Structured three-level routing architecture
- Defined review cycles rather than one-time optimisation sessions
- GDPR-compliant data management
- Referral pathways when pathology exceeds preventive scope
The clinic does not position itself as experimental, investigational, or outcome-guaranteeing. Its model emphasises measurement, interpretation, and structured oversight.
health.miro operates within a segment of the longevity sector that emphasises structured measurement over narrative positioning. In a field often characterised by trend-driven language, the clinic’s model centres on extended biomarker analysis, physician interpretation, and defined reporting cycles.
Longevity medicine remains evidence-evolving. Associations between biological age acceleration, inflammatory burden, and long-term health outcomes are supported by cohort research, yet individual prediction remains uncertain. No diagnostic model eliminates biological variability. Within this context, health.miro positions its services as probabilistic risk mapping rather than outcome assurance.
For executives and high-performing individuals, the clinic’s relevance lies in governance structure. Baseline mapping, interpretation sessions, and scheduled reassessment provide data-informed insight without requiring residential stays or extended disruption to professional commitments.
The clinic does not promise reversal of aging, disease prevention, or performance enhancement. Its offering is structured clarity under physician oversight within recognised UK medical standards.
Is health.miro a medical clinic or a wellness centre?
health.miro operates as a physician-led outpatient medical clinic in the United Kingdom. It is not a spa, retreat, or lifestyle centre. Diagnostic sequencing and reporting are conducted under the supervision of a UK-licensed General Practitioner.
Lifestyle variables such as nutrition, sleep, and metabolic regulation are discussed within a medical framework. The clinic does not provide recreational wellness services.
Who is the clinic designed for?
The clinic is structured for executives, founders, investors, professional athletes, and high-performing individuals seeking clarity around biomarker trends and long-term risk mapping.
It is not positioned for emergency care, inpatient treatment, or acute disease management.
How personalised is the process?
Personalisation begins with diagnostic depth. Testing may include extended biomarker panels, GI360 microbiome analysis, DUTCH hormone testing, Organic Acids Testing, and biological age modelling when clinically appropriate.
Interpretation is physician-led. No fixed protocol is applied universally. Personalisation refers to diagnostic sequencing and reporting cycles, not experimental treatment variation.
How is patient privacy handled?
health.miro operates under UK medical regulation and complies with the General Data Protection Regulation (GDPR). Clinical notes, laboratory data, and biological age modelling outputs are stored within secure, access-controlled systems.
Data is used for clinical interpretation only and not distributed without appropriate consent.
Can patients remain connected and working during programs?
Yes. The outpatient structure allows consultations to be integrated within professional schedules. Follow-up reporting sessions may be conducted remotely when appropriate.
There is no inpatient admission or residential requirement.
Does the clinic treat diabetes or chronic conditions?
The clinic focuses on preventive risk mapping and biomarker interpretation. It does not replace specialist care for established chronic disease.
If diagnostics indicate pathology beyond preventive scope, referral to appropriate medical specialists is recommended. All medical decisions should be made in collaboration with a personal physician.
How should value be evaluated relative to cost?
Value is derived from diagnostic depth, physician interpretation time, and structured review cycles rather than single interventions.
The clinic’s model supports long-term oversight and risk transparency. It does not guarantee disease prevention or lifespan extension.
A Strategic Pause That Clarifies the Years Ahead
In high-performance environments, risk is rarely ignored. Financial exposure, operational uncertainty, and strategic volatility are measured, reviewed, and managed through structured oversight. Biological systems deserve similar discipline.
health.miro positions itself within a preventive framework built on extended biomarker mapping, physician interpretation, and defined review cycles. It does not promise reversal of aging or elimination of disease risk. It offers structured insight into metabolic, inflammatory, hormonal, and mitochondrial patterns that may influence long-term trajectory.
Longevity medicine remains evidence-evolving. Biological age models, inflammatory markers, and glycaemic indicators provide directional information, not certainty. Within that uncertainty, measured oversight can reduce blind spots.
For executives, founders, athletes, and high-performing individuals, the value lies not in intensity of intervention but in clarity of interpretation. The clinic’s outpatient structure allows integration into professional schedules without requiring residential retreat or extended downtime.
Preventive medicine, when approached conservatively, is less about urgency and more about intention.
👉 View Longevity Program
↩ Return to ExtendMy.Life
↑ Back to Top
Disclaimer
This page is provided for informational and editorial purposes only. It is intended to support structured review and informed decision-making. It does not constitute medical advice, diagnosis, or treatment.
Reading this content does not establish a doctor–patient relationship with health.miro, its physicians, or ExtendMy.Life. Clinical services are delivered only through formal consultation and individual medical assessment.
Longevity medicine and biological age modelling operate within probabilistic frameworks. Associations between biomarkers, aging patterns, inflammatory markers, and long-term health outcomes are primarily derived from observational and cohort research. These associations indicate population-level trends and do not guarantee individual outcomes.
Diagnostic findings represent biological patterns and risk indicators, not certainty of disease development or prevention. Individual results vary based on genetics, lifestyle, environmental exposure, adherence, and pre-existing medical conditions.
All medical decisions, including laboratory testing, medication use, hormone therapy, supplementation, or lifestyle modification, should be made in consultation with a qualified personal physician. ExtendMy.Life does not provide medical services and does not recommend specific treatments.
This page separates editorial analysis from clinical care and should not replace personalised medical consultation.
References
Aging Cell (2024) ‘Biological age modelling and longitudinal health outcomes’, Aging Cell, 23(2), e70142.
Belsky, D.W. et al. (2015) ‘Quantification of biological aging in young adults’, Proceedings of the National Academy of Sciences, 112(30), pp. E4104–E4110.
Ferrucci, L. and Fabbri, E. (2018) ‘Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty’, Nature Reviews Cardiology, 15(9), pp. 505–522.
Franceschi, C. et al. (2018) ‘Inflammaging and “Garb-aging”’, Trends in Endocrinology & Metabolism, 29(9), pp. 623–633.
Horvath, S. (2013) ‘DNA methylation age of human tissues and cell types’, Genome Biology, 14(10), R115.
Kennedy, B.K. et al. (2014) ‘Geroscience: linking aging to chronic disease’, Cell, 159(4), pp. 709–713.
Levine, M.E. et al. (2018) ‘An epigenetic biomarker of aging for lifespan and healthspan’, Aging (Albany NY), 10(4), pp. 573–591.
López-Otín, C. et al. (2013) ‘The hallmarks of aging’, Cell, 153(6), pp. 1194–1217.
Moffitt, T.E. et al. (2017) ‘Aging trajectories and multimorbidity risk’, Journals of Gerontology: Series A, 72(2), pp. 175–183.
Organisation for Economic Co-operation and Development (2024) Health at a Glance: Europe 2024. Paris: OECD Publishing.
World Health Organization (2022) Global report on ageing and health. Geneva: WHO.
